Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Baker

Showing results (151-160 of 200) with videos related to

Pageof 20
Sort By:
Biomed Research International|January 16, 2018
Enhancement of Nucleoside Production in <i>Hirsutella sinensis</i> Based on Biosynthetic Pathway AnalysisZhi-Qiang Liu, Bo Zhang, Shan Lin, et al.
Journal of Applied Clinical Medical Physics|May 14, 2024
Optimization of treatment workflow for 0.35T MR-Linac systemMojtaba Behzadipour, Jatinder Palta, Tianjun Ma, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedemaJonathan A Bernstein, Michael E Manning, Henry Li, et al.
Environmental Health Perspectives|October 17, 2007
Early childhood lower respiratory illness and air pollutionIrva Hertz-Picciotto, Rebecca James Baker, Poh-Sin Yap, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 10, 2021
Evaluation of recombinase-based isothermal amplification assays for point-of-need detection of SARS-CoV-2 in resource-limited settingsPrakash Ghosh, Rajashree Chowdhury, Mohammad Enayet Hossain, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2011
Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonistsPhillip M Cowley, James Baker, Kirsteen I Buchanan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 14, 2017
Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patientsPaula Busse, James Baker, Inmaculada Martinez-Saguer, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|May 9, 2025
Diagnosis of adult patients with intestinal failure-associated liver disease: A descriptive cross-sectional studyShameer J Mehta, Alexandra Zissimopoulos, Konstantinos Fragkos, et al.
Lancet (London, England)|July 30, 2017
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trialMarc A Riedl, Vesna Grivcheva-Panovska, Dumitru Moldovan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 8, 2006
Pharmacological characterization of novel water-soluble cannabinoidsBilly R Martin, Jenny L Wiley, Irina Beletskaya, et al.
Pageof 20

Showing results (151-160 of 200) with videos related to

Sort By:
Pageof 20
Biomed Research International|January 16, 2018
Enhancement of Nucleoside Production in <i>Hirsutella sinensis</i> Based on Biosynthetic Pathway AnalysisZhi-Qiang Liu, Bo Zhang, Shan Lin, et al.
Journal of Applied Clinical Medical Physics|May 14, 2024
Optimization of treatment workflow for 0.35T MR-Linac systemMojtaba Behzadipour, Jatinder Palta, Tianjun Ma, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedemaJonathan A Bernstein, Michael E Manning, Henry Li, et al.
Environmental Health Perspectives|October 17, 2007
Early childhood lower respiratory illness and air pollutionIrva Hertz-Picciotto, Rebecca James Baker, Poh-Sin Yap, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 10, 2021
Evaluation of recombinase-based isothermal amplification assays for point-of-need detection of SARS-CoV-2 in resource-limited settingsPrakash Ghosh, Rajashree Chowdhury, Mohammad Enayet Hossain, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2011
Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonistsPhillip M Cowley, James Baker, Kirsteen I Buchanan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 14, 2017
Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patientsPaula Busse, James Baker, Inmaculada Martinez-Saguer, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|May 9, 2025
Diagnosis of adult patients with intestinal failure-associated liver disease: A descriptive cross-sectional studyShameer J Mehta, Alexandra Zissimopoulos, Konstantinos Fragkos, et al.
Lancet (London, England)|July 30, 2017
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trialMarc A Riedl, Vesna Grivcheva-Panovska, Dumitru Moldovan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 8, 2006
Pharmacological characterization of novel water-soluble cannabinoidsBilly R Martin, Jenny L Wiley, Irina Beletskaya, et al.
Pageof 20